Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009

Serogroup W135 Meningococcal Meningitis, Northern Cameroon, 2007–2008

Denis MassenetComments to Author , Jermias Inrombe, Dave-Etienne Mevoula, and Pierre Nicolas
Author affiliations: Centre Pasteur du Cameroun, Garoua, Cameroon (D. Massenet); Délégation de la Santé du Nord, Garoua (J. Inrombe); Délégation de la Santé de l'Extrême-Nord, Maroua, Cameroon (D.-E. Mevoula); Institut de Médecine Tropicale du Service de Santé des Armées, Marseilles, France (P. Nicolas)

Main Article


CSF specimens from Cameroon tested at CPCAG laboratory in 2007 and 2008 and number of health facilities that sent specimens, compared with 2006 efforts*

Characteristic 2006 2007 2008†
No. tested CSF specimens 60 202 207
Health facilities involved Garoua Hospital Garoua Hospital plus 8 other health facilities Garoua Hospital plus 17 other health facilities
Specimens not collected in Garoua 0 27 79

*CSF, cerebrospinal fluid; CPCAG, Centre Pasteur du Cameroun in Garoua.
†Through June 30.

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.